ABATI, ELENA
ABATI, ELENA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Investigating the role of serum NfL, FGF21, NCAM1 and GDF15 as disease biomarkers for Charcot-Marie-Tooth type 2A
2026 E. Abati, D. Saccomanno, C. Alberti, A. Anastasia, D. Gagliardi, E. Ferri, B. Arosio, G. D Angelo, R. Cima, M.T. Bassi, S. Oldoni, G.P. Comi, P. Rizzo, S.P. Corti
Case Report: Acute onset hemiparesis in a young man: do not miss Crohn's disease
2025 V. Iacobelli, S. Tagliabue, B. Modello, D. Velardo, E. Abati, F. Triulzi, G.P. Comi, S. Corti, D. Gagliardi, M. Parisi
Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models
2025 M. Rizzuti, E. Pagliari, M. D'Agostino, L. Ottoboni, V. Parente, G.P. Comi, S. Corti, F. Rizzo, E. Abati
Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy
2025 M. Rimoldi, S. Lucchiari, S. Pagliarani, G. Meola, G.P. Comi, E. Abati
IN VIVO AND IN VITRO EVALUATION OF THE COMBINATION OF RNA INTERFERING AND GENE THERAPY FOR TREATING MITOFUSIN2-RELATED DISEASES
2024 E. Abati
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives
2024 C. Alberti, F. Rizzo, A. Anastasia, G. Comi, S. Corti, E. Abati
Shaping the Neurovascular Unit Exploiting Human Brain Organoids
2024 M. Rizzuti, V. Melzi, L. Brambilla, L. Quetti, L. Sali, L. Ottoboni, M. Meneri, A. Ratti, F. Verde, N. Ticozzi, G.P. Comi, S. Corti, E. Abati
Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy
2024 E. Abati, C. Alberti, V. Tambè, A. Esseridou, G.P. Comi, S. Corti, G. Meola, F. Secchi
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort
2024 E. Abati, D. Gagliardi, A. Manini, R. Del Bo, D. Ronchi, M. Meneri, F. Beretta, A. Sarno, F. Rizzo, E. Monfrini, A. Di Fonzo, M.T. Pellecchia, A. Brusati, V. Silani, G.P. Comi, A. Ratti, F. Verde, N. Ticozzi, S. Corti
Sleep and sleep-related breathing disorders in patients with spinal muscular atrophy: a changing perspective from novel treatments?
2024 E. Abati, E. Mauri, M. Rimoldi, B. Madini, F. Patria, G.P. Comi, S. Corti
Charcot-Marie-Tooth type 2A in vivo models: Current updates
2024 E. Abati, M. Rizzuti, A. Anastasia, G.P. Comi, S. Corti, F. Rizzo
A rare association of Guillain-Barré syndrome/Miller-Fisher syndrome overlap syndrome and Herpes Simplex Virus Type 1 infection: trigger or exacerbating factor?
2024 C. Alberti, N. Molitierno, V. Iacobelli, D. Velardo, G.P. Comi, S. Corti, M. Parisi, E. Abati
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A
2023 F. Rizzo, S. Bono, M.D. Ruepp, S. Salani, L. Ottoboni, E. Abati, V. Melzi, C. Cordiglieri, S. Pagliarani, R. De Gioia, A. Anastasia, M. Taiana, M. Garbellini, S. Lodato, P. Kunderfranco, D. Cazzato, D. Cartelli, C. Lonati, N. Bresolin, G. Comi, M. Nizzardo, S. Corti
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
2023 M. Meneri, E. Abati, D. Gagliardi, I. Faravelli, V. Parente, A. Ratti, F. Verde, N. Ticozzi, G.P. Comi, L. Ottoboni, S. Corti
Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study
2023 I. Faravelli, D. Gagliardi, E. Abati, M. Meneri, J. Ongaro, F. Magri, V. Parente, L. Petrozzi, G. Ricci, F. Farè, G. Garrone, M. Fontana, D. Caruso, G. Siciliano, G.P. Comi, A. Govoni, S. Corti, L. Ottoboni
Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
2022 E. Abati, A. Manini, G.P. Comi, S. Corti
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
2022 E. Abati, A. Manini, D. Velardo, R. Del Bo, L. Napoli, F. Rizzo, M. Moggio, N. Bresolin, E. Bellone, M.T. Bassi, M.G. D'Angelo, G.P. Comi, S. Corti
Adeno-Associated Virus (AAV)-mediated gene therapy for Duchenne muscular dystrophy : the issue of transgene persistence
2022 A. Manini, E. Abati, A. Nuredini, S. Corti, G.P. Comi
A cross-sectional survey study of the impact of COVID-19 pandemic on the training and quality of life of Italian medical residents in the Lombardy region
2022 E. Abati, L. Nelva Stellio, A. Manini, F. Moroni, L. Azzalini, L.M. Vilca
Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction : a trembling balance
2022 A. Manini, E. Abati, G.P. Comi, S. Corti, D. Ronchi